Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis (Q36942534)

17 August 2017

0 references

1 reference

title

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis (English)

1 reference

17 August 2017

1 reference

1 reference

26

1 reference

17 August 2017

6

Albert Schömig

1 reference

17 August 2017

4

Adnan Kastrati

1 reference

17 August 2017

28

Stephan Windecker

1 reference

17 August 2017

29

Peter Jüni

1 reference

17 August 2017

8

Gregg W Stone

1 reference

17 August 2017

14

Maarten J Suttorp

1 reference

17 August 2017

9

Martin B Leon

1 reference

17 August 2017

1

Christoph Stettler

1 reference

17 August 2017

5

Marie Claude Morice

1 reference

17 August 2017

13

Manel Sabaté

1 reference

17 August 2017

17

Maurizio Menichelli

1 reference

17 August 2017

7

Matthias E Pfisterer

1 reference

17 August 2017

3

Sabin Allemann

1 reference

17 August 2017

2

Simon Wandel

1 reference

17 August 2017

11

Jean-Jacques Goy

1 reference

17 August 2017

16

Christian Spaulding

1 reference

17 August 2017

18

Paul Vermeersch

1 reference

17 August 2017

19

Maurits T Dirksen

1 reference

17 August 2017

23

Peter Diem

1 reference

17 August 2017

21

Anna Sonia Petronio

1 reference

17 August 2017

José Suarez de Lezo

10

1 reference

17 August 2017

Seung-Jung Park

12

1 reference

17 August 2017

Henning Kelbaek

15

1 reference

17 August 2017

Pavel Cervinka

20

1 reference

17 August 2017

Alain J Nordmann

22

1 reference

17 August 2017

Bernhard Meier

24

1 reference

17 August 2017

Marcel Zwahlen

25

1 reference

17 August 2017

Sven Trelle

27

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

17 August 2017

1 reference

17 August 2017

370

1 reference

17 August 2017

937-948

1 reference

17 August 2017

9591

1 reference

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study

17 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Meta-analysis comparing drug-eluting stents with bare metal stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Network meta-analysis for indirect treatment comparisons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Combination of direct and indirect evidence in mixed treatment comparisons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Simultaneous comparison of multiple treatments: combining direct and indirect evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Stent thrombosis in randomized clinical trials of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Clinical end points in coronary stent trials: a case for standardized definitions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Systematic reviews in health care: Assessing the quality of controlled clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Bayesian approaches to random-effects meta-analysis: a comparative study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Borrowing strength from external trials in a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Meta-analysis of mixed treatment comparisons at multiple follow-up times.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

The number needed to treat: a clinically useful measure of treatment effect

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Sirolimus-eluting versus uncoated stents in acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: the TAXi trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

"Head-to-head comparison between sirolimus-eluting and paclitaxel-eluting stents in patients with complex coronary artery disease: an intravascular ultrasound study".

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

The effects of misclassification on the estimation of relative risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Drug eluting stents: an updated meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Drug-eluting stents versus bare metal stents in percutaneous coronary interventions (a meta-analysis).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

Drug-eluting stents: an early systematic review to inform policy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

A meta-analysis of trials comparing Cypher and Taxus stents in patients with obstructive coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961444-5

7 January 2021

10.1016/S0140-6736(07)61444-5

Identifiers

DOI

1 reference

17 August 2017

1 reference